TABLE 3.
Effect of embryonic stage on microinjection efficiency in embryos of parthenogenetic strain B. mori 1–31 incubated at 15°C.
| Timing of injection after heat-shock activation (at 15°C) | No. of injected eggs | No. of died eggs | Expression of EGFP |
Hatched larvae | |
| Not expressed | Expressed | ||||
| 12 h | 48 | 12 (25%) | 2 (6%) | 34 (94%) | 0 (0%) |
| 18 h | 48 | 5 (10%) | 3 (7%) | 40 (93%) | 7 (16%) |
| 24 h | 48 | 10 (21%) | 2 (5%) | 36 (95%) | 2 (5%) |
| 30 h | 48 | 12 (25%) | 1 (3%) | 35 (97%) | 1 (3%) |
| 48 h | 48 | 3 (6%) | 30 (67%) | 15 (33%) | 3 (7%) |
| 72 h | 47 | 1 (2%) | 33 (72%) | 13 (28%) | 16 (35%) |
GFP-containing DNA plasmid was injected into the heat-shock-activated eggs during the first 72 h AEA at the times indicated in the first column. The number of GFP-positive embryos examined 4 days before hatching reflects the efficiency of microinjection. Mortality of injected embryos and hatchability success of transgenic larvae were also examined. The corresponding percentages are given in parentheses.